Tumour mutational burden is overestimated by target cancer gene panels
{{output}}
Background: Tumour mutational burden (TMB) has emerged as a predictive marker for responsiveness to immune checkpoint inhibitors (ICI) in multiple tumour types. It can be calculated from somatic mutations detected from whole exom... ...
